Innate Pharma to participate in the 10th Annual SVB Leerink Global Healthcare Conference

On February 17, 2021 Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) ("Innate" or the "Company") reported that members of its senior management team are scheduled to participate in the following upcoming virtual investor conference (Press release, Innate Pharma, FEB 17, 2021, View Source [SID1234575168]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

10th Annual SVB Leerink Global Healthcare Conference
Event Date: February 24-26, 2021
Fireside Chat: February 24, 2021 at 2:00-2:30 p.m. CET / 8:00-8:30 a.m. ET

A live webcast of the fireside chat will be available through the News & Events page of the Investors section of the Company’s website at www.innate-pharma.com. An archived replay of the webcast will be available for approximately 90 days following the presentation.